Gram-Negative Bacterial Infections
Information
- Disease name
- Gram-Negative Bacterial Infections
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00079989 | Completed | Phase 3 | Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms | December 2003 | November 2005 |
| NCT00177814 | Completed | Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit | September 2005 | June 2017 | |
| NCT00177957 | Completed | Gram Negative Bacteremia, Risk Factors for Failure of Therapy | April 2005 | May 2016 | |
| NCT00406198 | Completed | Phase 4 | Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis | March 1997 | December 1999 |
| NCT00490477 | Completed | Phase 3 | The Effects of Polymyxin-B Protects on Sepsis Induced Kidney Dysfunction: a Randomized Clinical Trial | May 2006 | December 2007 |
| NCT00629382 | Completed | Phase 4 | Early Use of Polymyxin B Hemoperfusion in Abdominal Sepsis | December 2004 | April 2008 |
| NCT00723502 | Completed | Phase 2 | Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients | September 2008 | April 2009 |
| NCT00874367 | Completed | Early-Onset Sepsis Surveillance Study | February 2006 | May 2011 | |
| NCT01732250 | Completed | Phase 4 | Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem | March 2013 | February 28, 2017 |
| NCT02088840 | Completed | Survey of Severe Infections by Gram Negative Bacteria in Patients Submitted to Stem Cell Transplant | January 2014 | April 2016 | |
| NCT02285075 | Completed | Phase 4 | Temocillin Pharmacokinetic in Hemodialysis | June 2011 | December 2014 |
| NCT02962934 | Completed | An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without CRRT | November 30, 2016 | August 2019 | |
| NCT03160040 | Completed | A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Minocin® (Minocycline) for Infections Caused by Gram-negative Bacteria in a Real World Setting | October 11, 2017 | May 1, 2018 | |
| NCT03182504 | Completed | Phase 1 | A Study to Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy Participants | June 15, 2017 | August 10, 2017 |
| NCT03397914 | Completed | Phase 4 | Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections | January 2017 | March 2019 |
| NCT04335539 | Completed | Phase 2 | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants | August 21, 2020 | February 6, 2023 |
| NCT06135350 | Not yet recruiting | Phase 2 | Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV | November 2023 | December 2024 |
| NCT04215991 | Recruiting | Phase 2 | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants | February 19, 2020 | September 30, 2024 |
| NCT04861922 | Recruiting | Phase 3 | Unfractioned Heparin for Treatment of Sepsis Caused by Abdominal Infection | May 11, 2021 | July 30, 2024 |
| NCT05639647 | Recruiting | Phase 2 | Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections | April 18, 2023 | February 18, 2026 |
| NCT06086626 | Recruiting | Phase 2 | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants | March 14, 2024 | December 31, 2024 |
| NCT00563134 | Suspended | N/A | A Randomised Trial on the Saftely and Efficacy of GR270774 in the Treatment of Gram-negative Sepsis in Adult | October 2005 | December 2006 |
| NCT05210387 | Terminated | N/A | Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections | January 27, 2022 | December 31, 2023 |
| NCT02666274 | Unknown status | Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread | December 2015 | June 2017 | |
| NCT05171257 | Unknown status | Quantifying Gram-negative Resistance to Empiric Therapy in the Intensive Care Unit | October 19, 2021 | December 30, 2022 | |
| NCT01600768 | Unknown status | N/A | Evaluation of Extended Intravenous of Beta-lactams in the Treatment of Serious Gram-negative Infections in Critically Ill Patients | February 2012 | December 2015 |
| NCT04055922 | Unknown status | Comparison of Solid Organ Transplant | May 3, 2018 | May 2021 | |
| NCT04917380 | Unknown status | The Clinical Character，Risk and Prognosis of Post-neurosurgical Intracranial Infection With Different Pathogens. | June 10, 2021 | October 30, 2021 | |
| NCT00394784 | Withdrawn | Surveillance Study - Incidence of Antibiotic Resistance in Serial Gram-negative Bloodstream Isolates | December 2006 | December 2025 | |
| NCT04785924 | Withdrawn | Phase 4 | Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections | June 7, 2021 | January 12, 2023 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D016905